FARNUM RHONDA (SVP, Comm & Medical Affairs) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2026ACC: 0001898490-26-000008
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
-5.68K
Net shares
Net seller
$94.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
5.68K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−5.68K
Price / share
$16.55
Trade value
$93.97K
% of position
2.3%
5/20/2026
251.45K→245.77K
Total
Net shares
−5.68K
Net value
-$93.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2026 | F · Tax Withholding | −5.68K | $16.55 | $93.97K | 2.3% | 251.45K | 245.77K |
| Total | −5.68K | -$93.97K | ||||||
Derivative Transactions0
No derivative transactions reported